Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global PD-L1 Biomarker Testing market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global PD-L1 Biomarker Testing market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category PD-L1 (22C3) PD-L1(28-8) PD-L1 (SP142) PD-L1 (SP263) Other Segmented by End User/Segment Hospital Diagnostic Center Others Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Roche Regeneron Ono Pharmaceutical Merck Junshi Biosciences Innovent Hengrui Medicine Bristol-Myers Squibb AstraZeneca Agilent Technologies

List of Tables

Table Global PD-L1 Biomarker Testing Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global PD-L1 Biomarker Testing Sales Value (Million USD) by Company (2019-2021)
Table Global PD-L1 Biomarker Testing Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers PD-L1 Biomarker Testing Sales Area
Table PD-L1 Biomarker Testing Market Concentration (Top 3, Top 5) (2019-2021)
Table Global PD-L1 Biomarker Testing Sales Value (Million USD) by Category (2016-2021)
Table Global PD-L1 Biomarker Testing Sals Value Market Share by Category (2016-2021)
Table North America PD-L1 Biomarker Testing Sales Value (Million USD) by Category (2016-2021)
Table North America PD-L1 Biomarker Testing Sales Value Market Share by Category (2016-2021)
Table Europe PD-L1 Biomarker Testing Sales Value (Million USD) by Category (2016-2021)
Table Europe PD-L1 Biomarker Testing Sales Value Market Share by Category (2016-2021)
Table Asia Pacific PD-L1 Biomarker Testing Sales Value (Million USD) by Category (2016-2021)
Table Asia Pacific PD-L1 Biomarker Testing Sales Value Market Share by Category (2016-2021)
Table Central & South America PD-L1 Biomarker Testing Sales Value (Million USD) by Category (2016-2021)
Table Central & South America Pacific PD-L1 Biomarker Testing Sales Value Market Share by Category (2016-2021)
Table Middle East & Africa PD-L1 Biomarker Testing Sales Value (Million USD) by Category (2016-2021)
Table Middle East & Africa PD-L1 Biomarker Testing Sales Value Market Share by Category (2016-2021)
Table Global PD-L1 Biomarker Testing Sales Value (Million USD) by End User/Segment (2016-2021)
Table Global PD-L1 Biomarker Testing Value Market Share by End User/Segment (2016-2021)
Table North America PD-L1 Biomarker Testing Sales Value (Million USD) by End User/Segment (2016-2021)
Table North America PD-L1 Biomarker Testing Sales Value Market Share by End User/Segment (2016-2021)
Table Europe PD-L1 Biomarker Testing Sales Value (Million USD) by End User/Segment (2016-2021)
Table Europe PD-L1 Biomarker Testing Sales Value Market Share by End User/Segment (2016-2021)
Table Asia Pacific PD-L1 Biomarker Testing Sales Value (Million USD) by End User/Segment (2016-2021)
Table Asia Pacific PD-L1 Biomarker Testing Sales Value Market Share by End User/Segment (2016-2021)
Table Central & South America PD-L1 Biomarker Testing Sales Value (Million USD) by End User/Segment (2016-2021)
Table Central & South America Pacific PD-L1 Biomarker Testing Sales Value Market Share by End User/Segment (2016-2021)
Table Middle East & Africa PD-L1 Biomarker Testing Sales Value (Million USD) by End User/Segment (2016-2021)
Table Middle East & Africa PD-L1 Biomarker Testing Sales Value Market Share by End User/Segment (2016-2021)
Table Global PD-L1 Biomarker Testing Sales Value (Million USD) by Region (2016-2021)
Table Global PD-L1 Biomarker Testing Value Market Share by Region (2016-2021)
Table North America PD-L1 Biomarker Testing Sales Value (Million USD) by Country (2016-2021)
Table North America PD-L1 Biomarker Testing Value Market Share by Country (2016-2021)
Table Europe PD-L1 Biomarker Testing Sales Value (Million USD) by Country (2016-2021)
Table Europe PD-L1 Biomarker Testing Value Market Share by Country (2016-2021)
Table Asia Pacific PD-L1 Biomarker Testing Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific PD-L1 Biomarker Testing Value Market Share by Country (2016-2021)
Table Central & South America PD-L1 Biomarker Testing Sales Value (Million USD) by Country (2016-2021)
Table Central & South America PD-L1 Biomarker Testing Value Market Share by Country (2016-2021)
Table Middle East & Africa PD-L1 Biomarker Testing Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa PD-L1 Biomarker Testing Value Market Share by Country (2016-2021)
Table Global PD-L1 Biomarker Testing Value (Million USD) Forecast by Category (2022-2027)
Table Global PD-L1 Biomarker Testing Value Market Share Forecast by Category (2022-2027)
Table Global PD-L1 Biomarker Testing Value (Million USD) Forecast by End User/Segment (2022-2027)
Table Global PD-L1 Biomarker Testing Value Market Share Forecast by End User/Segment (2022-2027)
Table Global PD-L1 Biomarker Testing Value (Million USD) Forecast by Region (2022-2027)
Table Global PD-L1 Biomarker Testing Value Market Share Forecast by Region (2022-2027)
Table Roche Company Information
Table Roche Product Introduction
Table Roche PD-L1 Biomarker Testing Sales Value, Gross Margin and Global Share (2019-2021)
Table Regeneron Company Information
Table Regeneron Product Introduction
Table Regeneron PD-L1 Biomarker Testing Sales Value, Gross Margin and Global Share (2019-2021)
Table Ono Pharmaceutical Company Information
Table Ono Pharmaceutical Product Introduction
Table Ono Pharmaceutical PD-L1 Biomarker Testing Sales Value, Gross Margin and Global Share (2019-2021)
Table Merck Company Information
Table Merck Product Introduction
Table Merck PD-L1 Biomarker Testing Sales Value, Gross Margin and Global Share (2019-2021)
Table Junshi Biosciences Company Information
Table Junshi Biosciences Product Introduction
Table Junshi Biosciences PD-L1 Biomarker Testing Sales Value, Gross Margin and Global Share (2019-2021)
Table Innovent Company Information
Table Innovent Product Introduction
Table Innovent PD-L1 Biomarker Testing Sales Value, Gross Margin and Global Share (2019-2021)
Table Hengrui Medicine Company Information
Table Hengrui Medicine Product Introduction
Table Hengrui Medicine PD-L1 Biomarker Testing Sales Value, Gross Margin and Global Share (2019-2021)
Table Bristol-Myers Squibb Company Information
Table Bristol-Myers Squibb Product Introduction
Table Bristol-Myers Squibb PD-L1 Biomarker Testing Sales Value, Gross Margin and Global Share (2019-2021)
Table AstraZeneca Company Information
Table AstraZeneca Product Introduction
Table AstraZeneca PD-L1 Biomarker Testing Sales Value, Gross Margin and Global Share (2019-2021)
Table Agilent Technologies Company Information
Table Agilent Technologies Product Introduction
Table Agilent Technologies PD-L1 Biomarker Testing Sales Value, Gross Margin and Global Share (2019-2021)

Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global PD-L1 Biomarker Testing Market Status and Forecast (2016-2027) 1.3.2 Global PD-L1 Biomarker Testing Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global PD-L1 Biomarker Testing Supply by Company 2.1 Global PD-L1 Biomarker Testing Sales Value by Company 2.2 PD-L1 Biomarker Testing Sales Area of Main Manufacturers 2.3 Trend of Concentration Rate3 Global and Regional PD-L1 Biomarker Testing Market Status by Category 3.1 PD-L1 Biomarker Testing Category Introduction 3.1.1 PD-L1 (22C3) 3.1.2 PD-L1(28-8) 3.1.3 PD-L1 (SP142) 3.1.4 PD-L1 (SP263) 3.1.5 Other 3.2 Global PD-L1 Biomarker Testing Market by Category 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional PD-L1 Biomarker Testing Market Status by End User/Segment 4.1 PD-L1 Biomarker Testing Segment by End User/Segment 4.1.1 Hospital 4.1.2 Diagnostic Center 4.1.3 Others 4.2 Global PD-L1 Biomarker Testing Market by End User/Segment 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global PD-L1 Biomarker Testing Market Status by Region 5.1 Global PD-L1 Biomarker Testing Market by Region 5.2 North America PD-L1 Biomarker Testing Market Status 5.3 Europe PD-L1 Biomarker Testing Market Status 5.4 Asia Pacific PD-L1 Biomarker Testing Market Status 5.5 Central & South America PD-L1 Biomarker Testing Market Status 5.6 Middle East & Africa PD-L1 Biomarker Testing Market Status6 North America PD-L1 Biomarker Testing Market Status 6.1 North America PD-L1 Biomarker Testing Market by Country 6.2 United States 6.3 Canada 6.4 Mexico7 Europe PD-L1 Biomarker Testing Market Status 7.1 Europe PD-L1 Biomarker Testing Market by Country 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific PD-L1 Biomarker Testing Market Status 8.1 Asia Pacific PD-L1 Biomarker Testing Market by Country 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America PD-L1 Biomarker Testing Market Status 9.1 Central & South America PD-L1 Biomarker Testing Market by Country 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa PD-L1 Biomarker Testing Market Status 10.1 Middle East & Africa PD-L1 Biomarker Testing Market by Country 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Major Downstream Customers Analysis 11.1 Customer One Analysis 11.2 Customer Two Analysis 11.3 Customer Three Analysis 11.4 Customer Four Analysis12 Global PD-L1 Biomarker Testing Market Forecast by Category and by End User/Segment 12.1 Global PD-L1 Biomarker Testing Sales Value Forecast (2022-2027) 12.2 Global PD-L1 Biomarker Testing Forecast by Category 12.3 Global PD-L1 Biomarker Testing Forecast by End User/Segment13 Global PD-L1 Biomarker Testing Market Forecast by Region/Country 13.1 Global PD-L1 Biomarker Testing Market Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Roche 14.1.1 Company Information 14.1.2 PD-L1 Biomarker Testing Product Introduction 14.1.3 Roche PD-L1 Biomarker Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.1.4 SWOT Analysis 14.2 Regeneron 14.2.1 Company Information 14.2.2 PD-L1 Biomarker Testing Product Introduction 14.2.3 Regeneron PD-L1 Biomarker Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.2.4 SWOT Analysis 14.3 Ono Pharmaceutical 14.3.1 Company Information 14.3.2 PD-L1 Biomarker Testing Product Introduction 14.3.3 Ono Pharmaceutical PD-L1 Biomarker Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.3.4 SWOT Analysis 14.4 Merck 14.4.1 Company Information 14.4.2 PD-L1 Biomarker Testing Product Introduction 14.4.3 Merck PD-L1 Biomarker Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.4.4 SWOT Analysis 14.5 Junshi Biosciences 14.5.1 Company Information 14.5.2 PD-L1 Biomarker Testing Product Introduction 14.5.3 Junshi Biosciences PD-L1 Biomarker Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.5.4 SWOT Analysis 14.6 Innovent 14.6.1 Company Information 14.6.2 PD-L1 Biomarker Testing Product Introduction 14.6.3 Innovent PD-L1 Biomarker Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.6.4 SWOT Analysis 14.7 Hengrui Medicine 14.7.1 Company Information 14.7.2 PD-L1 Biomarker Testing Product Introduction 14.7.3 Hengrui Medicine PD-L1 Biomarker Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.7.4 SWOT Analysis 14.8 Bristol-Myers Squibb 14.8.1 Company Information 14.8.2 PD-L1 Biomarker Testing Product Introduction 14.8.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.8.4 SWOT Analysis 14.9 AstraZeneca 14.9.1 Company Information 14.9.2 PD-L1 Biomarker Testing Product Introduction 14.9.3 AstraZeneca PD-L1 Biomarker Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.9.4 SWOT Analysis 14.10 Agilent Technologies 14.10.1 Company Information 14.10.2 PD-L1 Biomarker Testing Product Introduction 14.10.3 Agilent Technologies PD-L1 Biomarker Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.10.4 SWOT Analysis15 Conclusion16 Methodology